EASD: Low-Dose Aspirin Tied to Lower Risk for New Diabetes in Older Adults

TUESDAY, Sept. 5, 2023 (HealthDay News) -- Aspirin treatment reduces the risk for incident diabetes in older adults, according to a study to be presented at the annual meeting of the European Association for the Study of Diabetes, held from Oct. 2 to 6 in Hamburg, Germany.
Sophia Zoungas, Ph.D., from Monash University in Melbourne, Australia, and colleagues investigated the treatment effect of low-dose aspirin on incident diabetes and fasting plasma glucose (FPG) levels among adults aged 65 years. and older. The participants (16,209 adults) were randomly assigned (1:1) to 100 mg daily enteric-coated aspirin or placebo.
The researchers found that during a median follow-up of 4.7 years, incident diabetes cases were identified in 459 participants in the aspirin group and 536 in the placebo group. The aspirin group had a lower risk for incident diabetes (hazard ratio, 0.85; P = 0.01) and a slower rate of increase in FPG (difference in annual FPG change, −0.006 mmol/L; P = 0.004).
“Given the increasing prevalence of type 2 diabetes among older adults, the potential for anti-inflammatory agents like aspirin to prevent type 2 diabetes or improve glucose levels needs further study,” the authors write.
Related Posts
Obesity Linked to COPD, Asthma in Pre-, Postmenopausal Women
FRIDAY, March 4, 2022 (HealthDay News) -- For premenopausal and postmenopausal...
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important...
USDA Cracks Down on Salmonella in Breaded Stuffed Raw Chicken Products
WEDNESDAY, April 26, 2023 (HealthDay News) -- The U.S. Department of Agriculture...
Shift Work Tied to Negative Impact on Cognitive Functioning
FRIDAY, Aug. 25, 2023 (HealthDay News) -- Shift work may negatively impact...